United States · FDA National Drug Code directory
Gefitinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50742-366_932e3701-75ae-438f-bb6a-2c2662c73ee5
- Product NDC
- 50742-366
- Form
- TABLET, COATED
- Composition / generic term
- Gefitinib
- Labeler
- Ingenus Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230427
- Source listing expiry
- 20261231
Source-listed ingredients
- GEFITINIB — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, COATED in 1 BOTTLE (50742-366-30) · 50742-366-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →